Cargando…

A Novel Rab9 Effector Required for Endosome-to-TGN Transport

Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active...

Descripción completa

Detalles Bibliográficos
Autores principales: Díaz, Elva, Schimmöller, Frauke, Pfeffer, Suzanne R.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138197/
https://www.ncbi.nlm.nih.gov/pubmed/9230071
_version_ 1782143507106889728
author Díaz, Elva
Schimmöller, Frauke
Pfeffer, Suzanne R.
author_facet Díaz, Elva
Schimmöller, Frauke
Pfeffer, Suzanne R.
author_sort Díaz, Elva
collection PubMed
description Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active form of Rab9. We report here the discovery of a 40-kD protein (p40) that binds Rab9–GTP with roughly fourfold preference to Rab9–GDP. p40 does not interact with Rab7 or K-Ras; it also fails to bind Rab9 when it is bound to GDI. The protein is found in cytosol, yet a significant fraction (∼30%) is associated with cellular membranes. Upon sucrose density gradient flotation, membrane- associated p40 cofractionates with endosomes containing mannose 6-phosphate receptors and the Rab9 GTPase. p40 is a very potent transport factor in that the pure, recombinant protein can stimulate, significantly, an in vitro transport assay that measures transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. The functional importance of p40 is confirmed by the finding that anti-p40 antibodies inhibit in vitro transport. Finally, p40 shows synergy with Rab9 in terms of its ability to stimulate mannose 6-phosphate receptor transport. These data are consistent with a model in which p40 and Rab9 act together to drive the process of transport vesicle docking.
format Text
id pubmed-2138197
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21381972008-05-01 A Novel Rab9 Effector Required for Endosome-to-TGN Transport Díaz, Elva Schimmöller, Frauke Pfeffer, Suzanne R. J Cell Biol Article Rab9 GTPase is required for the transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network in living cells, and in an in vitro system that reconstitutes this process. We have used the yeast two-hybrid system to identify proteins that interact preferentially with the active form of Rab9. We report here the discovery of a 40-kD protein (p40) that binds Rab9–GTP with roughly fourfold preference to Rab9–GDP. p40 does not interact with Rab7 or K-Ras; it also fails to bind Rab9 when it is bound to GDI. The protein is found in cytosol, yet a significant fraction (∼30%) is associated with cellular membranes. Upon sucrose density gradient flotation, membrane- associated p40 cofractionates with endosomes containing mannose 6-phosphate receptors and the Rab9 GTPase. p40 is a very potent transport factor in that the pure, recombinant protein can stimulate, significantly, an in vitro transport assay that measures transport of mannose 6-phosphate receptors from endosomes to the trans-Golgi network. The functional importance of p40 is confirmed by the finding that anti-p40 antibodies inhibit in vitro transport. Finally, p40 shows synergy with Rab9 in terms of its ability to stimulate mannose 6-phosphate receptor transport. These data are consistent with a model in which p40 and Rab9 act together to drive the process of transport vesicle docking. The Rockefeller University Press 1997-07-28 /pmc/articles/PMC2138197/ /pubmed/9230071 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Díaz, Elva
Schimmöller, Frauke
Pfeffer, Suzanne R.
A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title_full A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title_fullStr A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title_full_unstemmed A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title_short A Novel Rab9 Effector Required for Endosome-to-TGN Transport
title_sort novel rab9 effector required for endosome-to-tgn transport
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2138197/
https://www.ncbi.nlm.nih.gov/pubmed/9230071
work_keys_str_mv AT diazelva anovelrab9effectorrequiredforendosometotgntransport
AT schimmollerfrauke anovelrab9effectorrequiredforendosometotgntransport
AT pfeffersuzanner anovelrab9effectorrequiredforendosometotgntransport
AT diazelva novelrab9effectorrequiredforendosometotgntransport
AT schimmollerfrauke novelrab9effectorrequiredforendosometotgntransport
AT pfeffersuzanner novelrab9effectorrequiredforendosometotgntransport